CTC Clinical Trial Consultants

Activities: Regulatory

Trending Articles

  1. Catalent and AstraZeneca to expand support for COVID-19 vaccine AZD1222 Catalent will prepare the Harmans facility, close to Baltimore-Washington International (BWI) airport, to enable multiple production trains to run in parallel to produce the...
  2. Scleroderma treatment by Certa Therapeutics granted US FDA fast track FT011 is a novel, first-in-class oral therapy for the treatment of chronic fibrosis in multiple organs
  3. Naobios and Sumagen sign exclusive partnership to develop HIV vaccine Naobios will manage process development and initiate launch of cGMP manufacturing for phase II clinical trials
  4. Rapid increase in purchasing teams expected at CPHI North America Macro-uncertainty and large CDMO acquisitions attributed to have driven a surge in R&D, purchasing and QC/QA attendees at event
  5. Bio-Rad and Oncocyte partner to commercialise transplant monitoring with Droplet Digital PCR The collaboration aims to provide researchers with tools to enable transformational monitoring of key biomarkers in solid tissue transplants

Upcoming event

Making Pharmaceuticals

23–24 April 2024 | Exhibition | Coventry, UK See all

Related Content

You need to be a subscriber to read this article.
Click here to find out more.
Manufacturing

From formulation to clinic

Shaping an integrated drug development roadmap
Regulatory

Recipharm and CTC launch integrated first in human service

Contract development and manufacturing organisation (CDMO) Recipharm and contract research organisation (CRO) Clinical Trial Consultants (CTC) have partnered to launch a new service that delivers a clear, streamlined pathway to first in human milestones
Research & Development

Recipharm and CTC Clinical Trial form new Phase I pact

Aiming to shorten project time lines
Subscribe now